Abstract
The superoxide anion radical is a highly reactive toxic species produced during metabolic processes. Several copper (II) complexes with peptides are known to show superoxide dismutase (SOD) activity but those having a peptide with a non-natural amino acid are limited. The synthesis of HisAibGly peptide and its complexation with copper (II) ions has been reported. The interaction of the synthetic peptide with Cu(II) was studied by electron spray ionization-mass (ESIMS), circular dichroism (CD), absorption (UV-Vis) and electron paramagnetic resonance (EPR) spectroscopic methods. The solution studies and species distribution were performed by both spectrophotometric and potentiometric methods. The studies were performed at 25 ± 0.1 °C with constant ionic strength (μ = 0.1 M NaNO3) in aqueous solution using Bjerrum- Calvins pH-titration technique as adopted by Irving and Rossotti for binary systems. The species distribution stidies indicated that the complexation occurred from 3-11 pH and a three nitrogen coordinated species predominates at 8-9 whereas a four nitrogen coordinated species was formed between pH 9-11. The copper-peptide complex was tested for SOD activity using xanthine-xanthine oxidase ‐ nitroblue tetrazolium (NBT) methods.
Protein & Peptide Letters
Title: Copper (II) – HisAibGly Complex and Its Superoxide Dismutase Activity (Suplementary Material)
Volume: 17 Issue: 2
Author(s): Raj K. Singh, Sudhanand Prasad and Udai P. Singh
Affiliation:
Abstract: The superoxide anion radical is a highly reactive toxic species produced during metabolic processes. Several copper (II) complexes with peptides are known to show superoxide dismutase (SOD) activity but those having a peptide with a non-natural amino acid are limited. The synthesis of HisAibGly peptide and its complexation with copper (II) ions has been reported. The interaction of the synthetic peptide with Cu(II) was studied by electron spray ionization-mass (ESIMS), circular dichroism (CD), absorption (UV-Vis) and electron paramagnetic resonance (EPR) spectroscopic methods. The solution studies and species distribution were performed by both spectrophotometric and potentiometric methods. The studies were performed at 25 ± 0.1 °C with constant ionic strength (μ = 0.1 M NaNO3) in aqueous solution using Bjerrum- Calvins pH-titration technique as adopted by Irving and Rossotti for binary systems. The species distribution stidies indicated that the complexation occurred from 3-11 pH and a three nitrogen coordinated species predominates at 8-9 whereas a four nitrogen coordinated species was formed between pH 9-11. The copper-peptide complex was tested for SOD activity using xanthine-xanthine oxidase ‐ nitroblue tetrazolium (NBT) methods.
Export Options
About this article
Cite this article as:
Singh K. Raj, Prasad Sudhanand and Singh P. Udai, Copper (II) – HisAibGly Complex and Its Superoxide Dismutase Activity (Suplementary Material), Protein & Peptide Letters 2010; 17 (2) . https://dx.doi.org/10.2174/092986610790226012
DOI https://dx.doi.org/10.2174/092986610790226012 |
Print ISSN 0929-8665 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5305 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Targeting Histone Deacetylases for the Treatment of Immune, Endocrine & Metabolic Disorders
Endocrine, Metabolic & Immune Disorders - Drug Targets Renin-Angiotensin-Aldosterone System: A Current Drug Target for the Management of Neuropathic Pain
Current Drug Targets On the Relationship Between the Light/Dark Cycle, Melatonin and Oxidative Stress
Current Pharmaceutical Design The 21st Century Form of Vitamin E - Tocotrienol
Current Pharmaceutical Design Redefining the Role of Long-Acting Phosphodiesterase Inhibitor Tadalafil in the Treatment of Diabetic Erectile Dysfunction
Current Diabetes Reviews Cognitive Impacts of Estrogen Treatment in Androgen-Deprived Males: What Needs to be Resolved
Current Neuropharmacology Functional Components from Nature-Derived Drugs for the Treatment of Rheumatoid Arthritis
Current Drug Targets Liposomes as Versatile Platform for Cancer Theranostics: Therapy, Bio-imaging, and Toxicological Aspects
Current Pharmaceutical Design GEFT, A Rho Family Guanine Nucleotide Exchange Factor, Regulates Lens Differentiation through a Rac1-Mediated Mechanism
Current Molecular Medicine Editorial (Thematic Issue: NADPH Oxidase-Derived ROS Signaling and Therapeutic Opportunities)
Current Pharmaceutical Design Integrins as Therapeutic Targets for Respiratory Diseases
Current Molecular Medicine An Overview of Current Applications of Nanotechnology in Biomedical Research: A Patent Survey
Recent Patents on Nanomedicine Impact of Nutrition Transition and Resulting Morbidities on Economic and Human Development
Current Diabetes Reviews Advances and Future Challenges in Adenoviral Vector Pharmacology and Targeting
Current Gene Therapy Immunotherapy with Tumor Vaccines for the Treatment of Malignant Gliomas
Current Drug Discovery Technologies Modified Polysaccharides as Carriers for Biomolecules
Pharmaceutical Nanotechnology Metal Nanoparticle-Based Detection for DNA Analysis
Current Pharmaceutical Biotechnology Mononuclear Phagocyte Accumulation in Visceral Tissue in HIV Encephalitis: Evidence for Increased Monocyte/Macrophage Trafficking and Altered Differentiation
Current HIV Research Dietary Antioxidants as Potential Pharmacological Agents for Ischemic Stroke
Current Medicinal Chemistry The Role of Intrinsically Disordered Regions in the Structure and Functioning of Small Heat Shock Proteins
Current Protein & Peptide Science